Skip to main
MLYS
MLYS logo

Mineralys Therapeutics Inc (MLYS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy MLYS Stock

About Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by...read more
Market cap$933.31M
Today's volume1
Revenue (TTM)
Avg. daily volume945.62K
EBITDA (TTM)-$201.44M
Open$14.57
Price / earnings ratio-3.83x
Today's range$14.18 - $14.91
Debt / equity
52 week range$8.24 - $18.38
5 year debt / equity
Beta (LTM)0.83x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio26.48x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

MLYS Stock Rating

What analysts recommend for MLYS stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 63%
Buy 25%
Hold 13%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for MLYS stock is $933.32M

The current P/E ratio for MLYS stock is -3.83

The 52-week high for MLYS stock is $18.38. The current MLYS stock price $undefined is 100.00% below its 52-week high

The 52-week low for MLYS stock is $8.24. The current MLYS stock price $undefined has increased 100.00% from its 52-week low

No, the MLYS stock does not pay dividends to its shareholders

The target price for MLYS stock is $32.62 based on the average of what a group of analyst think MLYS stock could be worth at a future date. This is not a prediction by Public.com

How to buy MLYS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MLYS stock

    Navigate to the Explore page. Then, type MLYS into the search bar. When you see MLYS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MLYS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Mineralys Therapeutics Inc Stock Earnings

The value each MLYS share was expected to gain vs. the value that each MLYS share actually gained.

MLYS (MLYS) reported Q1 2025 earnings per share (EPS) of -$0.79, beating estimates of -$0.98 by 19.39%. In the same quarter last year, MLYS's earnings per share (EPS) was -$0.70. MLYS is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of $0.

Buy MLYS Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.